Updates are available Correction dated 2025-03-14
Click to view Correction: https://doi.org/10.1007/s00464-025-11668-7
-
Authors
Huang, Lin https://orcid.org/0000-0002-6768-1141
Brunelli, Alessandro https://orcid.org/0000-0002-6505-1656
Stefanou, Demetrios
Zanfrini, Edoardo
Donlagic, Abid
Gonzalez, Michel https://orcid.org/0000-0001-8705-4279
Petersen, René Horsleben https://orcid.org/0000-0002-3586-1869
-
Funding
Funding for this research was provided by:
Rigshospitalet (R163-A7357-B5343)
Novo Nordisk Fonden (NNF22OC0079013)
National Hospital
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 2 February 2025
First Online: 13 February 2025
Change Date: 14 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00464-025-11668-7
Declarations
:
: René Horsleben Petersen reports speaker fees from Medtronic, Medela, AstraZeneca, and AMBU and advisory board fees for AstraZeneca, MSD, BMS, and Roche. Alessandro Brunelli reports speakers and advisory board fees for Astra Zeneca, BMS, MSD, Ethicon, Medtronic, Medela, and Roche. Michel Gonzalez reports speaker fees from Ethicon and Medtronic. The other authors have no conflict of interest to report. Lin Huang, Demetrios Stefanou, Edoardo Zanfrini, and Abid Donlagic have no conflicts of interest to disclose.
